A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...
Neither clinical trials nor an application for federal approval from the Food and Drug Administration (FDA) are underway, meaning it's highly unlikely the state-manufactured insulin will be ...
Inc., the nonprofit drug manufacturer contracted to produce insulin for California, has not started clinical trials or applied for approval from the federal Food and Drug Administration, both of which ...
The company estimates that its install base surpassed 15,000 by the end of last year, leading to sales of more than $20 ...
Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose ...
has announced that the US Food and Drug Administration (FDA) has cleared Tidepool Loop, an automated insulin dosing app intended for the management of type 1 diabetes (T1D) in those six years old ...
This article highlights recent developments in healthcare, including the U.S. FDA's approval of Alzheimer's and diabetes ...
It also caps insulin ... could impact drug prices by curbing research into cost-reduction models and suggests that reducing drug prices is not a priority for the Trump administration.
The final proposed model would have had Medicare pay less for drugs that receive accelerated approvals from the Food and Drug ...
On the first day of his second term, President Donald Trump signed an executive order revoking dozens of the Biden administration ... model capping insulin costs at $35 per month for people on ...